Simon, Roger http://orcid.org/0000-0001-7287-6915
Meller, Robert
Yang, Tao
Pearson, Andrea
Wilson, Glenn
Funding for this research was provided by:
National Institutes of Health (R41 NS086267)
Article History
Received: 4 September 2018
Revised: 19 October 2018
Accepted: 19 November 2018
First Online: 8 December 2018
Compliance with Ethical Standards
: All animal experimental protocols were reviewed and approved by the Morehouse School of Medicine Institutional Review Board (IRB), in accordance with guidelines established by the Association for Assessment and Accreditation of Laboratory Animal Care International. The manuscript was written in accordance with the Animal Research: Reporting in vivo Experiments (ARRIVE) guidelines (ExternalRef removed; accessed May 2017).
: GW is a founder of Exscien a company that has developed EndoIII (excscien1-III) as a commercial product). RS has a 10% interest in Exscien.RM, TY, and AP all declare no conflicting interests.